Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN's Fistulas.

PHASE2RecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

July 31, 2028

Study Completion Date

October 31, 2028

Conditions
Crohn Disease
Interventions
COMBINATION_PRODUCT

local co-administration of autologous ADIpose

local co-administration of autologous ADIpose derived stromal vascular fraction and microfat for refractory perianal CROHN's fistulas Each batch of the final product is composed of one 5 mL syringes containing 25,9 +/- 10,7 millions viable cells. Each syringe will be obstructed with a sterile stopper and packaged in an external packaging.

OTHER

placebo

local co-administration of placebo The study placebo will consist of a saline solution for intralesional administration and will follow the same administration schema described for the SFV

Trial Locations (1)

13354

RECRUITING

Assistance Publique Des Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER